A Risk-Benefit Assessment of the Levonorgestrel-Releasing Intrauterine System
- 1 December 1996
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 15 (6) , 430-440
- https://doi.org/10.2165/00002018-199615060-00006
Abstract
The levonorgestrel-releasing intrauterine system (LNG-IUS), has been developed by Leiras Pharmaceuticals, Turku, Finland. It is a new systemic hormonal contraceptive that releases levonorgestrel 20µg...Keywords
This publication has 51 references indexed in Scilit:
- Sustained-release estradiol implants and a levonorgestrel-releasing intrauterine device in hormone replacement therapyAmerican Journal of Obstetrics and Gynecology, 1995
- The non-contraceptive effects of the levonorgestrel-releasing intrauterine deviceAdvances in Contraception, 1994
- Three years' experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: a randomized comparative studyAdvances in Contraception, 1992
- Serum SHBG levels during normal menstrual cycle and after insertion of levonorgestrel-releasing IUDAdvances in Contraception, 1992
- Das Levonorgestrel-IntrauterinpessarGeburtshilfe und Frauenheilkunde, 1989
- The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulationInternational Journal of Gynecology & Obstetrics, 1988
- Endometrial Morphology During Long-Term Use of Levonorgestrel-Releasing Intrauterine DevicesInternational Journal of Gynecological Pathology, 1986
- EFFICACY OF DIFFERENT CONTRACEPTIVE METHODSThe Lancet, 1982
- Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive deviceContraception, 1982
- INTRAUTERINE CONTRACEPTION WITH LEVONORGESTREL: A COMPARATIVE RANDOMISED CLINICAL PERFORMANCE STUDYThe Lancet, 1981